chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Having strange neurologic reaction; Burning sensation; Tingling; Sore Muscle; Sore Joint; Nervous sensation inside my body all the way from neck to my toe; Feeling like a nerve storm going on; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE DOSE and dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date the patient had having strange neurologic reaction, burning sensation, tingling, sore muscle, sore joint and nervous sensation inside my body all the way from neck to my toe; Feeling like a nerve storm going on. It was reported that patient received second vaccine shot on Wednesday and patient had very strange neurologic reaction, burning sensation, tingling, sore muscle, sore joint and just a nervous sensation inside body all the way from neck to my toe feeling like a nerve storm going on. It was reported that patient thought it started with the first shot and amplified (not clarified) with the second shot. patient need to get some immediate help (treatment). Reporter seriousness for events was Unspecified. The outcome of events was unknown.   Information about lot/batch number has been be obtained.
Information has been received from a medical assistant referring to an patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported. On 29-NOV-2018, the patient was vaccinated with improperly stored GARDASIL 9 (lot # R019470, expiration date: 10-APR-2021, strength, dose, frequency and route unknown) for prophylaxis (Incorrect product storage). No adverse effects were reported. The vaccine was exposed to temperature of 47 Fahrenheit (F) for 37 minutes. The temperature excursion was detected by a data logger. Previous temperature excursions were reported as 47 Fahrenheit (F) for 50 minutes. Sender's Comments: US-009507513-1901USA009289: US-009507513-1901USA009290: US-009507513-1901USA009291: US-009507513-1901USA009292: US-009507513-1901USA009293: US-009507513-1901USA009294: US-009507513-1901USA009295: US-009507513-1901USA009296: US-009507513-1901USA009297: US-009507513-1901USA009298: US-009507513-1901USA009299: US-009507513-1901USA009300: US-009507513-1901USA009301: US-009507513-1901USA009302: US-009507513-1901USA009303: US-009507513-1901USA009304: US-009507513-1901USA009305: US-009507513-1901USA009306: US-009507513-1901USA009307: US-009507513-1901USA009308: US-009507513-1901USA009309: US-009507513-1901USA009310: US-009507513-1901USA009311: US-009507513-1901USA009312: US-009507513-1901USA009313.
I really never had any adverse effects but reported everything from The very first vaccine in March 2021. Now these 7 months after the bivalent dose Nov 2, 2022 ... Sat May 20th, I presented with Bells Palsy or BP symptoms. Never had anything like that
Itching at vaccine location; Severe soreness; Swelling; Redness; More sleepy during the day/Sleeping more at night; This case was reported by a consumer and described the occurrence of injection site itching in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included levothyroxine and topiramate (Topamax).   On 23rd January 2023, the patient received Shingrix. In January 2023, less than a week after receiving Shingrix, the patient experienced pain, swelling, erythema and sleepiness. On 26th January 2023, the patient experienced injection site itching. On an unknown date, the outcome of the injection site itching was not recovered/not resolved and the outcome of the pain, swelling and erythema were recovering/resolving and the outcome of the sleepiness was unknown.   It was unknown if the reporter considered the injection site itching, pain, swelling, erythema and sleepiness to be related to Shingrix.     Additional Information: GSK Receipt Date: 28-JAN-2023 Reporter's Comment: The case was self reported by the patient. The patient received a dose of Shingrix and experienced itching at vaccine location and it was ongoing.  The patient had sever soreness, swelling and redness which was going down but not gone completely yet 5 days after vaccine and reported that itching started 2 days ago and was quite bad.  The patient also had been more sleepy than normal during the day and sleeping more at night. The patient received Levothyroxine and Topamax which was ongoing. The symptoms were not treated.  The reporter consented to follow up.
12/23/2015 - Fatigue, longer nap than usual, temperature, vomit that night; 12/24 - 12/29 - total loss of bladder control; 12/24-1/3/2016 - rash on both sides of buttocks up to hip area; rash reappeared in same area but worse from 1/8-1/11/2016; 12/24/2015 - 1/5/2015 - impaired lower extremity and trunk control affecting posture and locomotion; crawling instead of walking, fell off sofas and falling backwards while standing unable to catch herself/prevent fall; could not walk up stairs but instead crawled or dragged self up - right leg worse than left leg; right foot pointed and rotated. 1/5- 1/8 motor skills appeared to be improving but on 1/8-1/10 (same days that rash reappeared and was at its worst) patient crawled and "bear walked" on hands and knees instead of walking especially in the afternoon and had difficulty ascending stairs again. 12/31 loose stools / diarrhea. 12/23-present low grade temperature of approximately 99.4-99.7 in afternoons. 12/28-present - parents note change in behavior of unprovoked aggression towards parents and sisters.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medication were not reported. On 18-AUG-2016, the patient was inadvertently vaccinated with M-M-R II at a partial dose of about 0.3 ml (subcutaneous, lot # and expiration date unknown). No adverse effect was reported. Additional information has been requested.
Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Fever-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Headache-Severe, Systemic: Vomiting-Severe, Additional Details: Patient was out severly sick for 5 days. Experienced severe fatigue, nausea,vomiting, headache, fever and pain at injection site. Arm that it was given in was swollen
Left arm swollen, severe whelps/hives over body. Tylenol, Benadryl given. 3-4 hours after medications, hives decreased; gone by next day per mother.
Patient felt dizzy and fainted 5 minutes after vaccination with Fluvirin 15-16.  He regained consciousness immediately and was sweating.  BP was ~80-60.  Pt given and ice pack as well as orange juice and wafers for strength and BP resolved to 126/84 within 15 minutes.  No other medical attention was necessary and patient elected to go home shortly after.
Vaccine dose was given to the patient beyond-use-date. It was mixed at 4.05PM on 6/2/2021, left at room temperature in syringes and was given to the patient at 3:33PM on 6/3/2021.
numbness in arm 45 mins after shot; numbness in arm and shoulder 45 mins after shot/It radiated down arm, then to my lips, tongue and then to my right hip; It radiated down arm, then to my lips, tongue and then to my right hip.; Pain in arm 5 mins after shot; This is a spontaneous report from a contactable consumer (patient). A 44-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), intramuscular, administered in arm right on 25Jun2021 at 09:00 (at the age of 44-years-old) as dose 1, single for COVID-19 immunisation. Medical history included fibromyalgia from 09Sep2006 and ongoing, hypoglycemia, COVID-19 (if Covid prior vaccination: Yes) and known allergies: Latex, bananas, kiwi, avocado, steroids, all from an unknown date. Concomitant medications included ibuprofen (MOTRIN) taken for an unspecified indication, start and stop dates were not reported. The patient experienced pain in arm 5 mins after shot on 25Jun2021 at 09:05; numbness in arm 45 mins after shot, numbness in arm and shoulder 45 mins after shot/it radiated down arm, then to my lips, tongue and then to my right hip on 25Jun2021 at 09:45. The clinical course was as follows: 1st vaccine administered at 0900. Arm started going numb at 0945. It moved to right side of face and then right hip and went to ER once it moved to face. It took about 3 days for numbness to completely wear off. Events required visit to the Emergency room. The patient was hospitalized for the events. The patient underwent lab tests and procedures which included cardiac stress test: ok on 24Jun2021. There was no treatment received for the events. The outcome of the events was recovered on 27Jun2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 14-OCT-2012 at 12:55, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Arm swelled and turned purple. Swelling radiated to neck. Large lump in neck. Swelling in armpit. Pain from elbow to head.
Systemic: Nausea-Medium, Systemic: Felt faint, but no loss of conscious-Medium; symptoms lasted 1 day
Temperature of 102-103 during evening following shot. Fever lasted 24-48 hours. No other problems.
Knee hyperflexing; Lost nerve feeling and muscular control in right leg; Lost nerve feeling and muscular control in right leg; Fell back on right hip, tail bone and right wrist hard; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old, patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 14Apr2021 at 10:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and past drug history. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021 at 23:15, the patient stood up from toilet, lost nerve feeling and muscular control in right leg, could feel knee hyperflexing so fell back on right hip, tail bone and right wrist hard. Therapeutic measures were not reported. The clinical outcome of events lost nerve feeling and muscular control in right leg, could feel knee hyperflexing so fell back on right hip, tail bone and right wrist hard were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
(R) thigh red, warm, itchy swelling around site of DTaP. Non-tender, 10 cm diameter, NT, 5 mm (R) inguinal node.
1/11/2021 7pm whole body felt painful, chill, lower back pain, under armpit of injection side very painful.  Not able to get up this morning.  Took 1000mg Tylenol.  Last time took Tylenol was 1 am this morning.  Staff is worried.  Please advise. exposed 1/1/2021 (daughter).
Pt stated that she had fever of 101 degrees Fahrenheit, body aches, chills, mild headache, congestion runny nose, soreness and swelling at the injection site.
Increased heart rate after booster shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Nov2021 16:30 (Batch/Lot number: unknown) at the age of 56 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Allergies" (unspecified if ongoing), notes: Diagnosed allergies; "Compromised immune status" (unspecified if ongoing), notes: Compromised immune status; "Respiratory illness" (unspecified if ongoing), notes: Respiratory illness; "Genetic/chromosomal abnormalities" (unspecified if ongoing), notes: Genetic/chromosomal abnormalities; "Endocrine abnormalities" (unspecified if ongoing), notes: Endocrine abnormalities; "Diabetes" (unspecified if ongoing); "Obesity" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 01, Lot: EP6955, Expiration: Jun2021, Anatomical location: left arm), administration date: 27Mar2021, when the patient was 55 years old, for Covid-19 immunization, reaction(s): "AFib"; Bnt162b2 (Dose: 02, Lot: ER8731, Expiration: Jul2021, Anatomical location: left arm, Time: 1615 about), administration date: 19Apr2021, when the patient was 55 years old, for Covid-19 immunization, reaction(s): "AFib"; Flu shot, administration date: 01Nov2021, when the patient was 56 years old, for Immunization; Shingrix (Dose: 01, Manufacturer: Glaxo Smith Kline, Lot: t29Y2), administration date: 01Nov2021, when the patient was 56 years old, for Immunization; Shingrix (Dose:02, Lot: 54tf4, Manufacturer: Glaxo Smith Kline), administration date: 24Feb2022, for Immunization. The following information was reported: HEART RATE INCREASED (non-serious), outcome "not recovered", described as "Increased heart rate after booster shot". The event "increased heart rate after booster shot" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Clinical course: She received booster shot and then that day or the next day, anything she drinks caused her heartrate to go up. When laying down her heartrate went up. She was put on medication and when medication did not work they doubled the medication.   The lot number for bnt162b2 was not provided and will be requested during follow up.
shingles rash; This spontaneous case was reported by a pharmacist and describes the occurrence of HERPES ZOSTER (shingles rash) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced HERPES ZOSTER (shingles rash). In 2021, HERPES ZOSTER (shingles rash) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Drug details were reported.  No Treatment information was provided
Moderna Booster dose (0.25ml) inadvertently given to 7 year old
Very small headache.; Massive migraine; Extremely nauseous; Vertigo; My eyes are still watering and very very sensitive to the light; I did vomit when in a moving vehicle; I felt my balance was off; My eyes are still watering; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11May2021 11:00 (Lot number: EW0182) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "I have an intolerance to eggs" (unspecified if ongoing), notes: I have an intolerance to eggs. The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 12May2021 10:00, outcome "recovered with sequelae" (13May2021), described as "Very small headache."; MIGRAINE (non-serious) with onset 12May2021 10:00, outcome "recovered with sequelae" (2021), described as "Massive migraine"; NAUSEA (non-serious) with onset 12May2021 10:00, outcome "recovered with sequelae" (14May2021), described as "Extremely nauseous"; VERTIGO (non-serious) with onset 12May2021 10:00, outcome "recovered with sequelae" (2021), described as "Vertigo"; PHOTOPHOBIA (non-serious) with onset 12May2021 10:00, outcome "recovered with sequelae" (18May2021), described as "My eyes are still watering and very very sensitive to the light"; VOMITING (non-serious) with onset 12May2021 10:00, outcome "recovered with sequelae" (2021), described as "I did vomit when in a moving vehicle"; BALANCE DISORDER (non-serious) with onset 12May2021 10:00, outcome "recovered with sequelae" (2021), described as "I felt my balance was off"; LACRIMATION INCREASED (non-serious) with onset 12May2021, outcome "recovered with sequelae", described as "My eyes are still watering". Therapeutic measures were not taken as a result of headache, migraine, nausea, vertigo, photophobia, vomiting, balance disorder, lacrimation increased.  Additional information: Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient didn't have any other medications received within 2 weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. Patient had not been tested for COVID-19 since the vaccination. Patient driving to work around 10:45 am it was bright and sunny outside had eyes watering and headache starting to get a little worse. By 11:40 had a massive migraine and extremely nauseous. Patient was not able to drive home due to the intensity of the migraine.  Follow-up attempts completed. No further information expected.
Slight dizziness upon awakening in the morning around 7:00 AM.  dizziness faded through the day, but mild headache developed around 1;00PM.  Symptoms not severe or incapacitating.  Patient took two Tylenol caplets.
Large swollen area of upper arm where injection was given. Hot to the touch. Patient reported putting lotion on to try and help. After looking online, it appears patient has what is known as "Covid Arm"- fits the description and reported to us on day 11 after vaccine- she said symptoms started 10 days post vaccination.  Explained to the patient the information I found and explained it should resolve on its own.  If it did get worse, or if she did get a fever, it would be the best idea to seek medical attention. Told patient we would follow up with her in the next day or two to see how she was doing.
A 29 yr old Caucasian female who on 29-JUL-1999 and 14-SEP-1999 was vaccinated with the first and second dose of varicella virus vaccine live (site unknown. The pt became pregnant. Information received from a physician through a Merck pregnancy registry. In follow up the pt had routine pregnancy tests, all normal. An ultrasound done on 25-FEB-2000 was also normal. On 27-JUN-2000, the pt delivered a healthy, normal female birth weight 9 lbs and 6 oz. The rest of the text refers to the infant's visit to pediatrician for routine checkups and normal baby illnesses.
consumer reports that pt is deaf as poss result of vax; MFR of vax unk;
pt recvd vax;noticed pain,swelling,hardness in lt arm upper tissue area,on 9feb95;on exam today;21feb95 lt arm hard swollen;pt reports some numbness;
expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered). On 05-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired doses administered) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: 800-900 range (Inconclusive) Patients antibody numbers were in the 800-900 range.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Moderna vaccine (037C21A) was delivered in on 24 May2021 and immediately placed the vaccine into refrigerated storage. They indicated that the doctors did not know a 30-day expiration date applied to vaccines kept in the refrigerator and administered this vaccine to patients after this 30-day mark.  Patient did not report any adverse events or symptoms.  Concomitant medication was not reported. Treatment information was not reported.   This case was linked to MOD-2021-415889 (Patient Link).
itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itching at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Concomitant product use was not provided by the reporter.
Patient reports adverse event on arm where vaccine was injected  about a week later. She is experiencing swollen arm, warm to touch, red rashes, and itchiness.  Told patient to put cold compress and some hydrocortisone. Also to follow up with PCP.
Patient 24 years old male was suppose to receive his Bivalent booster but instead a third dose of Pfizer was given.  Contacted patient 3 times, 3 different day, no answer. Left messsage. Per CDC guidelines: Providers may administer 1 bivalent booster dose as a repeat dose based on clinical judgement and patient preference. In this case, space the repeat dose after the dose given in error by at least 2 month.
Headache, NauseaVomiting c/o light headiness. Told to follow up with primary care physician if no improvement Narrative:
Patient started to feel shortness of breath 10 minutes after receiving vaccine.  Patient suffers from anxiety. Vitals were taken:  BP 141/93, Pulse 116, O2 98%, PR 28 Breathing technique was used to calm patient along with therapeutic talk. Patient waited 15 minutes and felt well; she was cleared.